Gapping down
In reaction to earnings/guidance:
- BKR -0.9%
Other news:
- XYL -8.3% (AQUA to be acquired by Xylem in $7.5 bln all-stock transaction)
- BCRX -3.7% (enters collaboration with Swixx BioPharma AG to commercialize ORLADEYO (berotralstat) in Central and Eastern Europe)
- ABT -2.9% (being investigated by federal authorities over baby formula issues)
- VRAY -2.1% (reached an agreement with Hudson Executive Capital LP ") to appoint Sai Nanduri Senior Investment Analyst and representative of HEC as an observer of the ViewRay Board of Directors)
- MORF -1.8% (disclosed that Janssen has elected to terminate the Research Collaboration)
- EYPT -1.4% (enters lease agreement for manufacturing facility)
Analyst comments:
- VECO -2.3% (downgraded to Equal Weight from Overweight at Barclays)
- TPR -1.9% (downgraded to Equal Weight from Overweight at Barclays)
- WMG -1.9% (downgraded to Equal Weight from Overweight at Barclays)
- KLAC -1.6% (downgraded to Underweight from Equal Weight at Barclays)
- AMAT -1.4% (downgraded to Underweight from Equal Weight at Barclays)
- WDAY -1.3% (downgraded to Hold from Buy at Deutsche Bank)
- INGR -1.2% (downgraded to Equal Weight from Overweight at Barclays)
- S -1.1% (downgraded to Hold from Buy at Deutsche Bank)